Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Lion Bioscience acquires NetGenics

Executive Summary

Lion Bioscience (information management software for life sciences research and development) has acquired privately owned US-based bioinformatics company NetGenics. Lion issued 1.1mm shares of its stock in exchange for all of NetGenics' equity for a value of approximately $16.3mm (based on the average market price of Lion stock). The stock will be subject to a lock-up restriction for 180 days following the acquisition.
Deal Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register